- call +1-201-465-4211
- email sales@mrinsights.biz
Oral cancer, also known as mouth cancer, is a type of head and neck cancer and is any cancerous tissue growth located in the oral cavity. It may arise as a primary lesion originating in any of the tissues in the mouth, by metastasis from a distant site of origin, or by extension from a neighboring anatomic structure, such as the nasal cavity. Alternatively, the oral cancers may originate in any of the tissues of the mouth, and may be of varied histologic types: teratoma, adenocarcinoma derived from a major or minor salivary gland, lymphoma from tonsillar or other lymphoid tissue, or melanoma from the pigment-producing cells of the oral mucosa.
Scope of the Report:
This report studies the Oral Cancer Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Oral Cancer Treatment market by product type and applications/end industries.
There are several types of oral cancers, but around 90% are squamous cell carcinomas, originating in the tissues that line the mouth and lips. Oral or mouth cancer most commonly involves the tongue. It may also occur on the floor of the mouth, cheek lining, gingiva (gums), lips, or palate (roof of the mouth). In 2013 oral cancer resulted in 135,000 deaths up from 84,000 deaths in 1990. Five-year survival rates in the United States are 63%.
The global Oral Cancer Treatment market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Oral Cancer Treatment.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Bristol-Myers Squibb
Qilu Pharmaceutical
Teva Pharmaceutical Industries
Eli Lilly And Company
Roche
Merck
Novartis
Pfizer
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Squamous Cell Carcinoma
Verrucous Carcinoma
Minor Salivary Gland Carcinomas
Lymphomas
Market Segment by Applications, can be divided into
Hospitals & Clinics
Research Organization
Academic Institutes
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Oral Cancer Treatment Market Overview
1.1 Product Overview and Scope of Oral Cancer Treatment
1.2 Classification of Oral Cancer Treatment by Types
1.2.1 Global Oral Cancer Treatment Revenue Comparison by Types (2017-2023)
1.2.2 Global Oral Cancer Treatment Revenue Market Share by Types in 2017
1.2.3 Squamous Cell Carcinoma
1.2.4 Verrucous Carcinoma
1.2.5 Minor Salivary Gland Carcinomas
1.2.6 Lymphomas
1.3 Global Oral Cancer Treatment Market by Application
1.3.1 Global Oral Cancer Treatment Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospitals & Clinics
1.3.3 Research Organization
1.3.4 Academic Institutes
1.4 Global Oral Cancer Treatment Market by Regions
1.4.1 Global Oral Cancer Treatment Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Oral Cancer Treatment Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Oral Cancer Treatment Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Oral Cancer Treatment Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Oral Cancer Treatment Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Oral Cancer Treatment Status and Prospect (2013-2023)
1.5 Global Market Size of Oral Cancer Treatment (2013-2023)
2 Manufacturers Profiles
2.1 Bristol-Myers Squibb
2.1.1 Business Overview
2.1.2 Oral Cancer Treatment Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Bristol-Myers Squibb Oral Cancer Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.2 Qilu Pharmaceutical
2.2.1 Business Overview
2.2.2 Oral Cancer Treatment Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Qilu Pharmaceutical Oral Cancer Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.3 Teva Pharmaceutical Industries
2.3.1 Business Overview
2.3.2 Oral Cancer Treatment Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Teva Pharmaceutical Industries Oral Cancer Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.4 Eli Lilly And Company
2.4.1 Business Overview
2.4.2 Oral Cancer Treatment Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Eli Lilly And Company Oral Cancer Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.5 Roche
2.5.1 Business Overview
2.5.2 Oral Cancer Treatment Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Roche Oral Cancer Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.6 Merck
2.6.1 Business Overview
2.6.2 Oral Cancer Treatment Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Merck Oral Cancer Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.7 Novartis
2.7.1 Business Overview
2.7.2 Oral Cancer Treatment Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Novartis Oral Cancer Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.8 Pfizer
2.8.1 Business Overview
2.8.2 Oral Cancer Treatment Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Pfizer Oral Cancer Treatment Revenue, Gross Margin and Market Share (2016-2017)
3 Global Oral Cancer Treatment Market Competition, by Players
3.1 Global Oral Cancer Treatment Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Oral Cancer Treatment Players Market Share
3.2.2 Top 10 Oral Cancer Treatment Players Market Share
3.3 Market Competition Trend
4 Global Oral Cancer Treatment Market Size by Regions
4.1 Global Oral Cancer Treatment Revenue and Market Share by Regions
4.2 North America Oral Cancer Treatment Revenue and Growth Rate (2013-2018)
4.3 Europe Oral Cancer Treatment Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Oral Cancer Treatment Revenue and Growth Rate (2013-2018)
4.5 South America Oral Cancer Treatment Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Oral Cancer Treatment Revenue and Growth Rate (2013-2018)
5 North America Oral Cancer Treatment Revenue by Countries
5.1 North America Oral Cancer Treatment Revenue by Countries (2013-2018)
5.2 USA Oral Cancer Treatment Revenue and Growth Rate (2013-2018)
5.3 Canada Oral Cancer Treatment Revenue and Growth Rate (2013-2018)
5.4 Mexico Oral Cancer Treatment Revenue and Growth Rate (2013-2018)
6 Europe Oral Cancer Treatment Revenue by Countries
6.1 Europe Oral Cancer Treatment Revenue by Countries (2013-2018)
6.2 Germany Oral Cancer Treatment Revenue and Growth Rate (2013-2018)
6.3 UK Oral Cancer Treatment Revenue and Growth Rate (2013-2018)
6.4 France Oral Cancer Treatment Revenue and Growth Rate (2013-2018)
6.5 Russia Oral Cancer Treatment Revenue and Growth Rate (2013-2018)
6.6 Italy Oral Cancer Treatment Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Oral Cancer Treatment Revenue by Countries
7.1 Asia-Pacific Oral Cancer Treatment Revenue by Countries (2013-2018)
7.2 China Oral Cancer Treatment Revenue and Growth Rate (2013-2018)
7.3 Japan Oral Cancer Treatment Revenue and Growth Rate (2013-2018)
7.4 Korea Oral Cancer Treatment Revenue and Growth Rate (2013-2018)
7.5 India Oral Cancer Treatment Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Oral Cancer Treatment Revenue and Growth Rate (2013-2018)
8 South America Oral Cancer Treatment Revenue by Countries
8.1 South America Oral Cancer Treatment Revenue by Countries (2013-2018)
8.2 Brazil Oral Cancer Treatment Revenue and Growth Rate (2013-2018)
8.3 Argentina Oral Cancer Treatment Revenue and Growth Rate (2013-2018)
8.4 Colombia Oral Cancer Treatment Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Oral Cancer Treatment by Countries
9.1 Middle East and Africa Oral Cancer Treatment Revenue by Countries (2013-2018)
9.2 Saudi Arabia Oral Cancer Treatment Revenue and Growth Rate (2013-2018)
9.3 UAE Oral Cancer Treatment Revenue and Growth Rate (2013-2018)
9.4 Egypt Oral Cancer Treatment Revenue and Growth Rate (2013-2018)
9.5 Nigeria Oral Cancer Treatment Revenue and Growth Rate (2013-2018)
9.6 South Africa Oral Cancer Treatment Revenue and Growth Rate (2013-2018)
10 Global Oral Cancer Treatment Market Segment by Type
10.1 Global Oral Cancer Treatment Revenue and Market Share by Type (2013-2018)
10.2 Global Oral Cancer Treatment Market Forecast by Type (2018-2023)
10.3 Squamous Cell Carcinoma Revenue Growth Rate (2013-2023)
10.4 Verrucous Carcinoma Revenue Growth Rate (2013-2023)
10.5 Minor Salivary Gland Carcinomas Revenue Growth Rate (2013-2023)
10.6 Lymphomas Revenue Growth Rate (2013-2023)
11 Global Oral Cancer Treatment Market Segment by Application
11.1 Global Oral Cancer Treatment Revenue Market Share by Application (2013-2018)
11.2 Oral Cancer Treatment Market Forecast by Application (2018-2023)
11.3 Hospitals & Clinics Revenue Growth (2013-2018)
11.4 Research Organization Revenue Growth (2013-2018)
11.5 Academic Institutes Revenue Growth (2013-2018)
12 Global Oral Cancer Treatment Market Size Forecast (2018-2023)
12.1 Global Oral Cancer Treatment Market Size Forecast (2018-2023)
12.2 Global Oral Cancer Treatment Market Forecast by Regions (2018-2023)
12.3 North America Oral Cancer Treatment Revenue Market Forecast (2018-2023)
12.4 Europe Oral Cancer Treatment Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Oral Cancer Treatment Revenue Market Forecast (2018-2023)
12.6 South America Oral Cancer Treatment Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Oral Cancer Treatment Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Oral Cancer Treatment Picture
Table Product Specifications of Oral Cancer Treatment
Table Global Oral Cancer Treatment and Revenue (Million USD) Market Split by Prod
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
